FBXO3 and chronic myelogenous leukemia, BCR-ABL1 positive: FBXO3 deficiency induces apoptosis and reduces proliferation of CML cell lines and LSCs in vitro and in vivo, with minimal effects on normal CD34<sup>+</sup> hematopoietic stem cells (HSCs).